Global /China /Healthcare /Biotechnology /300404

Boji Medical Technology Co.,Ltd.

300404

• SHE: 300404 • Delayed

10.74CNY 1.4%

1.59 USD

As of 14 June 2026, Boji Medical Technology Co.,Ltd. has a market cap of $607.37M USD, ranking #13874 globally and #4249 in China. It ranks #1243 in the Healthcare sector, and #231 in the Biotechnology industry.

Global Rank

13874

Country Rank

4249

Sector Rank

1243

Industry Rank

231

Key Stats

Market Cap

$607.37MUSD

4.12B CNY

Enterprise Value

$561.14MUSD

3.8B CNY

Revenue (TTM)

$140.19MUSD

949.94M CNY

EBITDA (TTM)

$15.25MUSD

103.17M CNY

Net Income (TTM)

$6.35MUSD

43.05M CNY

EBITDA Margin

11%

Profit Margin

4.5%

PE Ratio

95.8

PS Ratio

4.3

PB Ratio

3.7

EV/EBITDA

36.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Tingchun Wang open_in_new

Employees

1,205

Founded

1998

Website

bojicro.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.4%	2.4%	9.3%	-0.1%	4.5%	14%	34%	4.4%	22%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300404 博济医药科技股份有限公司 Class A ISIN: CNE100001Y00 Shares Out.: Shares Outstanding: 383.082M¹ Shares Float: 356.439M² TV: TradingView: SZSE: 300404 SA: Stock Analysis: SHE: 300404 YF: Yahoo Finance: 300404.SZ GF: Google Finance: SHE: 300404 BA: Barron's: 300404 MS: Morningstar: XSHE: 300404	10.74 CNY	TV: TradingView: SZSE: 300404 SA: Stock Analysis: SHE: 300404 YF: Yahoo Finance: 300404.SZ GF: Google Finance: SHE: 300404 BA: Barron's: 300404 MS: Morningstar: XSHE: 300404

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Boji Medical Technology Co.,Ltd.

Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of technological achievements formed in the process of new drug research and development. The company was formerly known as Guangzhou Boji Medical & Biotechnological Co., Ltd. and changed its name to Boji Medical Technology Co.,Ltd. in September 2021. Boji Medical Technology Co.,Ltd. was founded in 1998 is headquartered in Guangzhou, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.44B 136.71B HKD 3K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 2K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.0B 54.23B CNY 1K%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.33B 49.69B CNY 1K%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 1K%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.72B 45.52B CNY 1K%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 30K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 26K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 8K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 7K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 7K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 7K%	37.2	Switzerland

chevron_leftBack